RECURSION PHARMACEUTICALS IN

Ticker: RXRX CUSIP: 75629V104 Class: Common Stock

PRELUDE CAPITAL MANAGEMENT, LLC's Holding History (CIK: 0001387508)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025

Shares 10,000 Value ($000) $41 Avg Close $4.95 Range $3.81 - $7.18

Q2 2024

Shares 15,794 Value ($000) $118 Avg Close $8.72 Range $6.75 - $10.66

Q4 2023

Shares 19,733 Value ($000) $195 Avg Close $7.13 Range $4.97 - $11.17

Q3 2023

Shares 42,959 Value ($000) $329 Avg Close $9.98 Range $6.44 - $16.75

Q2 2023

Shares 36,386 Value ($000) $272 Avg Close $7.00 Range $4.54 - $10.45

Q2 2022

Shares 18,243 Value ($000) $148 Avg Close $6.69 Range $4.92 - $9.40

Period	Shares	Value ($000)	Average Close	Price Range
Q4 2025	10,000	$41	$4.95	$3.81 - $7.18
Q2 2024	15,794	$118	$8.72	$6.75 - $10.66
Q4 2023	19,733	$195	$7.13	$4.97 - $11.17
Q3 2023	42,959	$329	$9.98	$6.44 - $16.75
Q2 2023	36,386	$272	$7.00	$4.54 - $10.45
Q2 2022	18,243	$148	$6.69	$4.92 - $9.40